Standard

Systemic Thrombolytic Therapy and Catheter-Directed Fragmentation with Local Thrombolytic Therapy in Patients with Pulmonary Embolism. / Klevanets, Julia; Starodubtsev, Vladimir; Ignatenko, Pavel et al.

In: Annals of Vascular Surgery, Vol. 45, 01.11.2017, p. 98-105.

Research output: Contribution to journalArticlepeer-review

Harvard

Klevanets, J, Starodubtsev, V, Ignatenko, P, Voroshilina, O, Ruzankin, P & Karpenko, A 2017, 'Systemic Thrombolytic Therapy and Catheter-Directed Fragmentation with Local Thrombolytic Therapy in Patients with Pulmonary Embolism', Annals of Vascular Surgery, vol. 45, pp. 98-105. https://doi.org/10.1016/j.avsg.2017.05.003

APA

Klevanets, J., Starodubtsev, V., Ignatenko, P., Voroshilina, O., Ruzankin, P., & Karpenko, A. (2017). Systemic Thrombolytic Therapy and Catheter-Directed Fragmentation with Local Thrombolytic Therapy in Patients with Pulmonary Embolism. Annals of Vascular Surgery, 45, 98-105. https://doi.org/10.1016/j.avsg.2017.05.003

Vancouver

Klevanets J, Starodubtsev V, Ignatenko P, Voroshilina O, Ruzankin P, Karpenko A. Systemic Thrombolytic Therapy and Catheter-Directed Fragmentation with Local Thrombolytic Therapy in Patients with Pulmonary Embolism. Annals of Vascular Surgery. 2017 Nov 1;45:98-105. doi: 10.1016/j.avsg.2017.05.003

Author

Klevanets, Julia ; Starodubtsev, Vladimir ; Ignatenko, Pavel et al. / Systemic Thrombolytic Therapy and Catheter-Directed Fragmentation with Local Thrombolytic Therapy in Patients with Pulmonary Embolism. In: Annals of Vascular Surgery. 2017 ; Vol. 45. pp. 98-105.

BibTeX

@article{8d50e81023d740e592939d3ef1908c18,
title = "Systemic Thrombolytic Therapy and Catheter-Directed Fragmentation with Local Thrombolytic Therapy in Patients with Pulmonary Embolism",
abstract = "Background The objective was to compare immediate and long-term results of systemic thrombolytic therapy (STT) and catheter-directed fragmentation (CDF) with local thrombolytic therapy (LTT) in patients with massive pulmonary embolism (PE). Methods About 209 patients with massive PE (the high risk of early death) were included in our study. From 2008 till 2010 in the first group (n = 102), STT was performed. From 2011 till 2013 in the second group (n = 107), CDF with LTT was carried out. Echocardiography and pulmonary arteriography were performed in all patients on admission to hospital and in 5 days after treatment. The patients of both groups were re-examined in 6 months, 1, 2, and 3 years after the operation. Results In the first group, there were 5 (4.9%) cases of in-hospital 30-day mortality. In the second group, there was 1 (0.9%) case of in-hospital 30-day mortality (P = 0.08). In the first group, a clinically significant bleeding was noted in 4 (3.9%) cases, but it caused mortality only in 1 case. In the second group, the clinically significant bleeding was not found (P = 0.038). Persistent postembolic pulmonary hypertension (PPPH) in 9.8% cases of patients in the first group and 2.9% cases of patients in the second group was determined (P = 0.048). Conclusions CDF combined with LTT is an effective minimal invasive treatment (helped us to reduce significantly the number of bleeding and PPPH cases), at least in the midterm, in patients with massive PE.",
author = "Julia Klevanets and Vladimir Starodubtsev and Pavel Ignatenko and Olga Voroshilina and Pavel Ruzankin and Andrey Karpenko",
year = "2017",
month = nov,
day = "1",
doi = "10.1016/j.avsg.2017.05.003",
language = "English",
volume = "45",
pages = "98--105",
journal = "Annals of Vascular Surgery",
issn = "0890-5096",
publisher = "Elsevier Science Inc.",

}

RIS

TY - JOUR

T1 - Systemic Thrombolytic Therapy and Catheter-Directed Fragmentation with Local Thrombolytic Therapy in Patients with Pulmonary Embolism

AU - Klevanets, Julia

AU - Starodubtsev, Vladimir

AU - Ignatenko, Pavel

AU - Voroshilina, Olga

AU - Ruzankin, Pavel

AU - Karpenko, Andrey

PY - 2017/11/1

Y1 - 2017/11/1

N2 - Background The objective was to compare immediate and long-term results of systemic thrombolytic therapy (STT) and catheter-directed fragmentation (CDF) with local thrombolytic therapy (LTT) in patients with massive pulmonary embolism (PE). Methods About 209 patients with massive PE (the high risk of early death) were included in our study. From 2008 till 2010 in the first group (n = 102), STT was performed. From 2011 till 2013 in the second group (n = 107), CDF with LTT was carried out. Echocardiography and pulmonary arteriography were performed in all patients on admission to hospital and in 5 days after treatment. The patients of both groups were re-examined in 6 months, 1, 2, and 3 years after the operation. Results In the first group, there were 5 (4.9%) cases of in-hospital 30-day mortality. In the second group, there was 1 (0.9%) case of in-hospital 30-day mortality (P = 0.08). In the first group, a clinically significant bleeding was noted in 4 (3.9%) cases, but it caused mortality only in 1 case. In the second group, the clinically significant bleeding was not found (P = 0.038). Persistent postembolic pulmonary hypertension (PPPH) in 9.8% cases of patients in the first group and 2.9% cases of patients in the second group was determined (P = 0.048). Conclusions CDF combined with LTT is an effective minimal invasive treatment (helped us to reduce significantly the number of bleeding and PPPH cases), at least in the midterm, in patients with massive PE.

AB - Background The objective was to compare immediate and long-term results of systemic thrombolytic therapy (STT) and catheter-directed fragmentation (CDF) with local thrombolytic therapy (LTT) in patients with massive pulmonary embolism (PE). Methods About 209 patients with massive PE (the high risk of early death) were included in our study. From 2008 till 2010 in the first group (n = 102), STT was performed. From 2011 till 2013 in the second group (n = 107), CDF with LTT was carried out. Echocardiography and pulmonary arteriography were performed in all patients on admission to hospital and in 5 days after treatment. The patients of both groups were re-examined in 6 months, 1, 2, and 3 years after the operation. Results In the first group, there were 5 (4.9%) cases of in-hospital 30-day mortality. In the second group, there was 1 (0.9%) case of in-hospital 30-day mortality (P = 0.08). In the first group, a clinically significant bleeding was noted in 4 (3.9%) cases, but it caused mortality only in 1 case. In the second group, the clinically significant bleeding was not found (P = 0.038). Persistent postembolic pulmonary hypertension (PPPH) in 9.8% cases of patients in the first group and 2.9% cases of patients in the second group was determined (P = 0.048). Conclusions CDF combined with LTT is an effective minimal invasive treatment (helped us to reduce significantly the number of bleeding and PPPH cases), at least in the midterm, in patients with massive PE.

UR - http://www.scopus.com/inward/record.url?scp=85021453475&partnerID=8YFLogxK

U2 - 10.1016/j.avsg.2017.05.003

DO - 10.1016/j.avsg.2017.05.003

M3 - Article

AN - SCOPUS:85021453475

VL - 45

SP - 98

EP - 105

JO - Annals of Vascular Surgery

JF - Annals of Vascular Surgery

SN - 0890-5096

ER -

ID: 9952541